Literature DB >> 9539786

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects.

S C Ghivizzani1, E R Lechman, R Kang, C Tio, J Kolls, C H Evans, P D Robbins.   

Abstract

Adenoviral vectors were used to deliver genes encoding a soluble interleukin 1 (IL-1)-type I receptor-IgG fusion protein and/or a soluble type I tumor necrosis factor alpha (TNFalpha) receptor-IgG fusion protein directly to the knees of rabbits with antigen-induced arthritis. When tested individually, knees receiving the soluble IL-1 receptor had significantly reduced cartilage matrix degradation and white blood cell infiltration into the joint space. Delivery of the soluble TNFalpha receptor was less effective, having only a moderate effect on white blood cell infiltration and no effect on cartilage breakdown. When both soluble receptors were used together, there was a greater inhibition of white blood cell infiltration and cartilage breakdown with a considerable reduction of synovitis. Interestingly, anti-arthritic effects were also seen in contralateral control knees receiving only a marker gene, suggesting that sustained local inhibition of disease activity in one joint may confer an anti-arthritic effect on other joints. These results suggest that local intra-articular gene transfer could be used to treat systemic polyarticular arthritides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539786      PMCID: PMC22538          DOI: 10.1073/pnas.95.8.4613

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-08-11       Impact factor: 15.470

2.  Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types.

Authors:  T J Wickham; P W Roelvink; D E Brough; I Kovesdi
Journal:  Nat Biotechnol       Date:  1996-11       Impact factor: 54.908

3.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.

Authors:  N Mittereder; K L March; B C Trapnell
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 4.  Biologic agents for treating rheumatoid arthritis. Concepts and progress.

Authors:  L W Moreland; L W Heck; W J Koopman
Journal:  Arthritis Rheum       Date:  1997-03

5.  Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo.

Authors:  B Henderson; E R Pettipher
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

6.  Quantitative histological analysis of antigen-induced arthritis in the rabbit.

Authors:  J C Edwards; N Read; B Trefty; J Coulstock; B Henderson
Journal:  Br J Exp Pathol       Date:  1988-10

7.  Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

Authors:  L W Moreland; S W Baumgartner; M H Schiff; E A Tindall; R M Fleischmann; A L Weaver; R E Ettlinger; S Cohen; W J Koopman; K Mohler; M B Widmer; C M Blosch
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

8.  Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective.

Authors:  U Müller-Ladner; C R Roberts; B N Franklin; R E Gay; P D Robbins; C H Evans; S Gay
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

9.  Adenoviral-mediated gene transfer to rabbit synovium in vivo.

Authors:  B J Roessler; E D Allen; J M Wilson; J W Hartman; B L Davidson
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

View more
  54 in total

Review 1.  New therapies in development for autoimmune diseases: their rationale for combination treatment.

Authors:  V Strand
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Gene therapy for rheumatoid arthritis.

Authors:  P D Robbins; C H Evans; Y Chernajovsky
Journal:  Springer Semin Immunopathol       Date:  1998

Review 3.  Tissue engineering tools for modulation of the immune response.

Authors:  Ryan M Boehler; John G Graham; Lonnie D Shea
Journal:  Biotechniques       Date:  2011-10       Impact factor: 1.993

Review 4.  In vitro selection technologies to enhance biomaterial functionality.

Authors:  Jonah C Rosch; Emma K Hollmann; Ethan S Lippmann
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-02

Review 5.  Recent tissue engineering-based advances for effective rAAV-mediated gene transfer in the musculoskeletal system.

Authors:  Ana Rey-Rico; Magali Cucchiarini
Journal:  Bioengineered       Date:  2016-04       Impact factor: 3.269

6.  Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis.

Authors:  Peter Wehling; Julio Reinecke; Axel W A Baltzer; Markus Granrath; Klaus P Schulitz; Carl Schultz; Rüdiger Krauspe; Theresa W Whiteside; Elaine Elder; Steven C Ghivizzani; Paul D Robbins; Christopher H Evans
Journal:  Hum Gene Ther       Date:  2009-02       Impact factor: 5.695

7.  TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis.

Authors:  P Mukherjee; B Wu; L Mayton; S-H Kim; P D Robbins; P H Wooley
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

Review 8.  Perspectives on the use of gene therapy for chronic joint diseases.

Authors:  Steven C Ghivizzani; Elvire Gouze; Jean-Noel Gouze; Jesse D Kay; Marsha L Bush; Rachael S Watson; Padraic P Levings; David M Nickerson; Patrick T Colahan; Paul D Robbins; Christopher H Evans
Journal:  Curr Gene Ther       Date:  2008-08       Impact factor: 4.391

9.  Intra-articular gene delivery and expression of interleukin-1Ra mediated by self-complementary adeno-associated virus.

Authors:  Jesse D Kay; Elvire Gouze; Thomas J Oligino; Jean-Noel Gouze; Rachael S Watson; Padraic P Levings; Marsha L Bush; Anthony Dacanay; David M Nickerson; Paul D Robbins; Christopher H Evans; Steven C Ghivizzani
Journal:  J Gene Med       Date:  2009-07       Impact factor: 4.565

Review 10.  Gene therapy of the rheumatic diseases: 1998 to 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.